Concepedia

R. Scott Pearsall

RS

Statistics

Publications

35

Citations

3K

H-Index

28

Active since

1996

Affiliations

Acceleron Pharma (United States)(Current)

Harvard University

Roswell Park Comprehensive Cancer Center

Beth Israel Deaconess Medical Center

Brigham and Women's Hospital

R. Scott Pearsall is an author at Acceleron Pharma (United States) specializing in life sciences, signal transduction, and cell signaling.

ORCID

Publications per year

1996–2022

35

Publications

35

Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis

Rajasekhar N.V.S. Suragani, Samuel M. Cadena, Sharon M Cawley et al. · Nature Medicine · 2014 · 428 citations

, , +10

ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension

Lai‐Ming Yung, Peiran Yang, Sachindra Raj Joshi et al. · Science Translational Medicine · 2020 · 234 citations · Full text

, , +14

Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth

Roselyne Castonguay, Eric D. Werner, Robert G. Matthews et al. · Journal of Biological Chemistry · 2011 · 222 citations · Full text

, , +11

ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth

Dianne Mitchell, Eileen G. Pobre, Aaron W. Mulivor et al. · Molecular Cancer Therapeutics · 2010 · 154 citations · Full text

, , +17

Characterization of the Ligand Binding Functionality of the Extracellular Domain of Activin Receptor Type IIB

Dianne Sako, Asya V. Grinberg, June Liu et al. · Journal of Biological Chemistry · 2010 · 150 citations · Full text

, , +15

1–5 of 35